Abstract
BackgroundPersonalized mRNA vaccines are promising new therapeutic options for patients with cancer. Because mRNA vaccines are not yet approved for first-line therapy, the vaccines are presently applied to individuals that...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have